Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05056753 · ClinicalTrials.gov registry record · NA
Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety
A NA study, sponsored by PhotoPharmics.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05056753: Completed NA study, sponsored by PhotoPharmics.
NCT05056753 is a NA study that has completed, run by PhotoPharmics. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05056753, a NA study, has completed, sponsored by PhotoPharmics.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
In this randomized, double-blind, controlled, parallel group study (conducted over 12-months), enrollment is expected of up to 60 subjects (30 men and 30 women) ages 18+ who are currently going through withdrawal of OUD and being treated at local substance abuse clinics. The study visits will include screening, baseline, Weeks 1, 2, 3, and 4, with both safety and efficacy assessments.
Primary Outcome
The Hamilton Anxiety Rating Scale (HAM-A) measures severity of anxiety, with 14 domains and is administered by a clinician. Severity is rated from 0 - 4 on each question, with a total possible of 56 points. A higher score is reflects worse severity
Interventions
- DEVICE HWBV chair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2023-07-30 |
| Phase | NA |
What the finished NCT05056753 record still lists
NCT05056753 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which HWBV chair is the first listed.
NCT05056753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05056753 about?
NCT05056753 is a clinical study titled "Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety". In this randomized, double-blind, controlled, parallel group study (conducted over 12-months), enrollment is expected of up to 60 subjects (30 men and 30 women) ages 18+ who are currently going through withdrawal of OUD and being treated at local substance abuse clinics. The study visits will includ...
What is the current status of trial NCT05056753?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-20. Estimated completion is 2023-07-30.
What interventions are being tested in trial NCT05056753?
The interventions under investigation include: HWBV chair (DEVICE).
Who is sponsoring clinical trial NCT05056753?
This trial is sponsored by PhotoPharmics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05056753's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI